Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for obstetricians/gynecologists/women’s health clinicians, family medicine/primary care practitioners, nurses, and other members of the healthcare team for women with history of preterm birth and/or endometriosis.
The goal of this activity is to describe the association between the presence of endometriosis and preterm birth and effect of disease phenotype on risk, according to a cohort study of women with singleton pregnancies with and without endometriosis enrolled from 7 maternity units in France from February 4, 2016 to June 28, 2018.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 3/18/2022
Valid for credit through: 3/18/2023
processing....
Endometriosis is an inflammatory disease with heterogeneous presentations affecting 10% to 15% of women of reproductive age. Findings of previous studies are conflicting regarding implications of endometriosis for pregnancy outcomes. A recent multicenter cohort study by Marcellin and colleagues evaluated over 1300 women with singleton pregnancies in France from February 4, 2016 to June 28, 2018, with final follow-up in July 2019. This study was published in the February 1, 2021 issue of JAMA Network Open.[1]
Using non-modifiable risk factors, researchers found that modifying pregnancy monitoring strategies beyond the normal protocols or may not be warranted in cases of endometriosis. Additionally, there was no correlation discovered between a mother's endometriosis phenotype and preterm birth rate.
These novel results by Marcellin and colleagues have incited a potential interest in further studies related to pregnancy risk and endometriosis that would be valuable to the healthcare team.
Researchers evaluating whether endometriosis is linked with preterm birth found no such association in a multicenter cohort study of more than 1300 women.
These new findings, which were published February 1 in JAMA Network Open,[1] suggest that changing monitoring strategies to prevent preterm birth for women with the disease may not be necessary.
The research team, led by Louis Marcellin, MD, PhD, with the department of obstetrics and gynecology at Université de Paris, in Paris, France, also found that disease phenotype or whether the preterm birth was induced or spontaneous did not appear to alter the result.
Those results differ from previous research. Data on the phenotypes and their link with preterm birth have been scarce, but previous studies have shown the risk for preterm birth is more pronounced in women who have deep endometriosis than in women with ovarian endometriosis.
Marcellin told Medscape Medical News, "Little is known about the impact of endometriosis on obstetric outcomes. In contrast to previous studies, we reported no differences in the risk for preterm delivery between women with endometriosis (34 of 470 [7.2%]) and those without endometriosis (53 of 881 [6.0%]), even when adjusted for multiple factors."
The authors accounted for mother's age, body mass index (BMI) before pregnancy, birth country, number of times the woman had given birth, previous cesarean delivery, and history of preterm birth. After adjusting for potential confounders, endometriosis was not associated with preterm birth (adjusted odds ratio [aOR] 1.07 [95% CI: 0.64, 1.77]).
The researchers found no differences among preterm births based on a mother's endometriosis phenotype. Those phenotypes include isolated superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA), and deep endometriosis (DE).
"Monitoring pregnancy beyond the normal protocols or changing management strategies may not be warranted in cases of endometriosis," Marcellin said.
More research on endometriosis' potential link to birth outcomes is needed.
An expert not involved with the study said the new paper highlights important new avenues of research but should not be seen as the final word on the connection between endometriosis and preterm birth.
Of the 1351 study participants (mean age, 32.9 ± 5 years) who had a singleton delivery after 22 weeks of gestation, 470 were assigned to the endometriosis group, and 881 were assigned to the control group.
The authors concluded, "Pregnant women with endometriosis should not be considered to have an exceptionally high risk for preterm birth. However, further studies are needed to examine the potential for other adverse perinatal outcomes or specific but rare complications."
Daniela Carusi, MD, said the difficulty with the study's design is that "premature birth is not one problem or one disease."
Many very different problems can all end with premature birth. Sometimes it's an infection or inflammation or bleeding in the uterus or hypertension in the mother, for example, and all those things can lead to a preterm birth, she explained.
"This study inherently lumps all those things together," said Carusi, who is director of surgical obstetrics and placental abnormalities in the department of obstetrics and gynecology at Brigham and Women's Hospital in Boston, Massachusetts. "It's quite possible endometriosis can have a big impact in one of those areas and no impact in the other areas, but the study design wouldn't be able to pick that up."
Editorialists: Results Challenge Findings of Previous StudiesIn an accompanying commentary,[2] Liisu Saavalainen, MD, PhD, and Oskari Heikinheimo, MD, PhD, both with the department of obstetrics and gynecology, and Helsinki University Hospital, in Helsinki, Finland, wrote that several previous studies have suggested that women with endometriosis have a slightly higher risk for preterm birth.
Those studies were mostly retrospective and differed in the way they classified endometriosis and the way they selected patients, the editorialists wrote. Also, most women in these studies typically had subfertility, they added.
The study by Marcellin and colleagues differs from previous related research in that it was prospective and assessed the risk for preterm delivery in women with endometriosis and women without endometriosis from several maternity centers in France. The women with endometriosis were classified according to the severity of their disease.
The editorialists wrote, "[T]he novel results by Marcellin et al challenge the findings of most previous studies on this topic. These results are valuable and comforting. However, they are also likely to trigger new studies on the pregnancy risks associated with different types of endometriosis That is good news."
Carusi said the study was well done and included a notably large size. Further complimenting the research, she said it is important to talk about this little-discussed pregnancy complication.
There has been much more focus for women with endometriosis and their physicians on getting pregnant and on talking about the length of their term, she said.
The study leaves some things unanswered.
The study was funded by research grants from the French Ministry of Health and was sponsored by the Département de la Recherche Clinique et du Développement de l'Assistance Publique–Hôpitaux de Paris. Carusi reports no relevant financial relationships. A coauthor of the study reports personal fees from Bioserinity and Ferring outside the submitted work. No other disclosures were reported.